Back to results
US 2010/0075935 A1Published application
Xanthine modulators of adenosine a1 receptor
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manouchehr M. Shahbaz
Life of this patent
Estimating the term…
Abstract
The present invention relates to new xanthine modulators of adenosine A1 receptors, pharmaceutical compositions thereof, and methods of use thereof.
Claims31
A compound of structural Formula I
- or a salt thereof, wherein:
- R1-R28 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R28 is deuterium.
1 more element
Dependencies are inferred from the claim text.